Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L E Hendriks, K M Kerr, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L E Hendriks, K M Kerr, J Menis, et al.
Journal of Endocrinological Investigation
|
June 28, 2018
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management
E Masiello, G Veronesi, D Gallo, et al.
Journal of Endocrinological Investigation
|
July 29, 2016
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study
L Bartalena, E Masiello, F Magri, et al.
Journal of Endocrinological Investigation
|
April 24, 2017
Physical performance in newly diagnosed hypothyroidism: a pilot study
D Gallo, E Piantanida, G Veronesi, et al.
Oncogene
|
October 26, 2010
Genomic characterization of asymptomatic CT-detected lung cancers
E Belloni, G Veronesi, C Micucci, et al.
ESMO Open
|
March 11, 2026
Somatic and germline genomic variation in thymic carcinomas
F Tettamanzi, C De Carlo, C Cappadona, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy
L Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L Bartalena, G Veronesi, G E Krassas, et al.
Journal of Endocrinological Investigation
|
July 22, 2019
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study
P Premoli, M L Tanda, E Piantanida, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L E Hendriks, K M Kerr, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L E Hendriks, K M Kerr, J Menis, et al.
Journal of Endocrinological Investigation
|
June 28, 2018
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management
E Masiello, G Veronesi, D Gallo, et al.
Journal of Endocrinological Investigation
|
July 29, 2016
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study
L Bartalena, E Masiello, F Magri, et al.
Journal of Endocrinological Investigation
|
April 24, 2017
Physical performance in newly diagnosed hypothyroidism: a pilot study
D Gallo, E Piantanida, G Veronesi, et al.
Oncogene
|
October 26, 2010
Genomic characterization of asymptomatic CT-detected lung cancers
E Belloni, G Veronesi, C Micucci, et al.
ESMO Open
|
March 11, 2026
Somatic and germline genomic variation in thymic carcinomas
F Tettamanzi, C De Carlo, C Cappadona, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy
L Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L Bartalena, G Veronesi, G E Krassas, et al.
Journal of Endocrinological Investigation
|
July 22, 2019
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study
P Premoli, M L Tanda, E Piantanida, et al.
Page
of 7